OPENING PLENARY AND INTRODUCTION TO IPVC

• Successful vaccines – what’s the secret?

Prof. Mark K. Slifka, USA

PLENARY SESSION 2

• Public trust in vaccines

Dr. Maya J. Goldenberg, Canada

• Immunotherapy for HPV

Dr. Sjoerd van der Burg, Netherlands

• Next-generation HPV vaccines integrating biology and engineering

Dr. Robert L. Garcea, USA

PLENARY SESSION 3

• Inequity in global access to health and justice

Dr. Gina Ogilvie. Canada

• Global HPV vaccine supply & demand and the impact of the COVID-19 pandemic

Dr. Tania Cernuschi, Switzerland

• Cervical cancer prevention and management as part of comprehensive sexual and reproductive health care for women in sub-Saharan Africa

Dr. Peter Jay Hotez, USA

14:30-15:30

PLENARY SESSION 4

• HNSCC development and progression: Avenues for therapeutic development

Dr. Jennifer R. Grandis, USA

• RRP: the paradigm for HPV immune evasion

Dr. Vincent R. Bonagura, USA

PLENARY SESSION 5

• Exploiting DNA damage repair by HPV

Prof. Laimonis A Laimins, USA

• The vaginal microbiome in viral susceptibility and cervical cancer

Prof. Adam Burgener, USA

15:30-17:00

CLOSING PLENARY

• Research in HPV: past, present, and future

Dr. Eduardo Franco, Canada